BIMI Holdings Inc.: Nasdaq/NYSE listing notice — BIMI receives Nasdaq delisting warning for failure to file Q3 10-Q; prior delinquency resolved

BIMI Holdings Inc.

On Nov 21, 2023, Nasdaq notified BIMI of non-compliance with Listing Rule 5250(c)(1) due to untimely Q3 10-Q filing.
Prior delinquency (Q2 10-Q) resolved with filing on Nov 22, 2023; deadline extension expires Feb 20, 2024.
Company must submit updated plan to regain compliance; no immediate effect on listing of shares.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

BIMI Holdings Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

November 21, 2023, BIMI International Medical Inc. (the “Company”) received a notification letter (the “Nasdaq Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Third Quarter Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq Letter also stated that Nasdaq ha

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-23-089981

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.